{"id":36551,"date":"2026-07-15T16:05:00","date_gmt":"2026-07-15T14:05:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=1023f11418197b5b65a4e6c9fde62e11"},"modified":"2026-07-15T16:05:00","modified_gmt":"2026-07-15T14:05:00","slug":"ionis-to-hold-second-quarter-2026-financial-results-webcast","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=36551","title":{"rendered":"Ionis to hold second quarter 2026 financial results webcast"},"content":{"rendered":"

Webcast scheduled for Wednesday, July 29 at 8:30 a.m. Eastern Time<\/i><\/p>

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, July 29 at 8:30 a.m. Eastern Time to discuss its second quarter 2026 financial results and highlight progress on key programs.<\/p><\/a><\/a>

The webcast may be accessed at https:\/\/ir.ionis.com\/events-and-presentations\/upcoming-events<\/a>. A replay will be available for a limited time at the same address.<\/p>

About Ionis Pharmaceuticals, Inc.<\/b><\/p>

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com<\/a> and follow us on X<\/a> (Twitter), LinkedIn<\/a> and Instagram<\/a>.<\/p> Contacts<\/b>

Ionis Investor Contact:<\/b>D. Wade Walke, Ph.D. \u2013 IR@ionis.com<\/a> \u2013 760-603-2331<\/p>

Ionis Media Contact:<\/b>Hayley Soffer \u2013 media@ionis.com<\/a> \u2013 760-603-4679<\/p>","protected":false},"excerpt":{"rendered":"

Webcast scheduled for Wednesday, July 29 at 8:30 a.m. Eastern TimeCARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, July 29 at 8:30 a.m. Eastern Time to discuss …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-36551","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/36551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=36551"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/36551\/revisions"}],"predecessor-version":[{"id":36552,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/36551\/revisions\/36552"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=36551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=36551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=36551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}